NEW YORK (GenomeWeb) – Chinese genetic testing firm Berry Genomics and Illumina have co-developed a next-generation sequencing system and are currently seeking approval for clinical applications from the Chinese Food and Drug Administration, the companies said today.

Under their partnership, the firms have developed a customized sequencer that is based on Illumina's NextSeq 500 and have integrated it with Berry's Bambni noninvasive prenatal test, which includes a PCR-free library prep kit and proprietary RUPATM analysis software.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Dog DNA testing finds that some purebreds might not truly be purebreds, Inside Edition reports.

Mary Beckerle has returned as director of the Huntsman Cancer Institute, according to ScienceInsider.

Smithsonian Magazine reports that environmental DNA sampling can be used to track elusive organisms.

In Genome Research this week: repetitive satellite DNA in the fruit fly, transcriptome map assembly pipeline, and more.